REGENXBIO Announces Dose Escalation in AFFINITY DUCHENNE® Trial ...Middle East

First patient received dose level 2 of RGX-202, a potential one-time AAV Therapeutic for the treatment of Duchenne that includes an optimized transgene for a novel microdystrophin On track for pivotal dose determination and initiation of pivotal program in 2024 ROCKVILLE, Md., Nov. 29,...

Hence then, the article about regenxbio announces dose escalation in affinity duchenne trial was published today ( Wednesday 29/11/2023 - 03:13 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( REGENXBIO Announces Dose Escalation in AFFINITY DUCHENNE® Trial )

Also on site :

• U.S. soccer star Landon Donovan was raised by a single mom and said he wouldn’t break though today because youth sports have gotten too expensive
• Grand Hyatt Is Launching Its First-Ever All-Inclusive Resort—See Inside This Stunning Los Cabos Coastal Hideaway
• We Asked 3 Travel Advisors Which Hawaii Bucket-List Cruise They Recommend Most—They All Said the Same Thing